MedTrace Logo

Antibiotic Prophylaxis in Laparoscopic Cholecystectomy

NCT01888822 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 138

Last updated 2020-03-25

No results posted yet for this study

Summary

The trial aims to assess the value of two-regimen antibiotic prophylaxis versus placebo in elective laparoscopic cholecystectomy.

Conditions

Interventions

DRUG

Ciprofloxacin

Prophylactic ciprofloxacin infusion before elective laparoscopic cholecystectomy

DRUG

Ampicillin-sulbactam

Prophylactic ampicillin-sulbactam infusion before elective laparoscopic cholecystectomy

DRUG

Placebo

Prophylactic placebo infusion before elective laparoscopic cholecystectomy

Sponsors & Collaborators

  • University of Roma La Sapienza

    lead OTHER

Principal Investigators

  • Erasmo Spaziani, MD, PhD · University of Roma La Sapienza

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2016-06-30
Completion
2017-06-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01888822 on ClinicalTrials.gov